中国麻风皮肤病杂志 ›› 2025, Vol. 41 ›› Issue (7): 533-537.doi: 10.12144/zgmfskin202507533

• 综述 • 上一篇    下一篇

痤疮治疗研究进展

李军友,刘白,吴瑾   

  1. 兰州大学第二医院皮肤科,甘肃兰州,730000
  • 出版日期:2025-07-15 发布日期:2025-07-07

Research progress on acne therapies

LI Junyou, LIU Bai, WU Jin   

  1. Department of Dermatology, The Second Hospital of Lanzhou University, Lanzhou 730000, China
  • Online:2025-07-15 Published:2025-07-07

摘要: 近年来痤疮新的治疗药物包括第四代外用维A酸类药物选择性RAR-γ激动剂曲法罗汀、外用米诺环素泡沫制剂4% FMX101、新型四环素类抗生素萨瑞环素、首个雄激素受体拮抗剂等。此外对原有药物剂型改良新技术的应用对于减少药物不良反应、提高疗效也取得了一定进展。本文对痤疮的临床治疗进展进行综述。

关键词: 痤疮, 药物治疗, 曲法罗汀, 米诺环素, 萨瑞环素, 雄激素拮抗剂

Abstract: In recent years, new treatments for acne include the fourth-generation selective topical retinoic acid receptor(RAR)-γ agonist trifarotene, the topical minocycline foam 4% (FMX101), the new tetracycline antibiotic sarecycline, the first androgen receptor antagonist clascoterone, etc.. In addition, the application of new technologies to improve the original drug dosage form has also made some progress in reducing adverse drug reactions and improving efficacy. We reviews the new progress of the treatments for acne in this paper.

Key words: acne, drug therapy, trifarotene, minocycline, sarecycline, androgen receptor antagonist